In fact, PI3K/Akt/mTOR signaling pathway was regarded as a potential therapeutic target in head and neck cancer including NPC39–41, and activated PI3K/Akt/mTOR signaling might induce proliferation, migration and invasion in NPC42,43. This evidence concerns the gene AKT1 and head and neck cancer.